Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001422848-25-000238
Filing Date
2025-11-13
Accepted
2025-11-13 10:29:34
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 5824
  Complete submission text file 0001422848-25-000238.txt   7688
Mailing Address 4250 CONGRESS STREET SUITE 900 CHARLOTTE NC 28209
Business Address 4250 CONGRESS STREET SUITE 900 CHARLOTTE NC 28209 980-299-5700
ALBEMARLE CORP (Subject) CIK: 0000915913 (see all company filings)

EIN.: 541692118 | State of Incorp.: VA | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-44053 | Film No.: 251476087
SIC: 2821 Plastic Materials, Synth Resins & Nonvulcan Elastomers
(CF Office: 08 Industrial Applications and Services)

Mailing Address 333 SOUTH HOPE STREET 55TH FL LOS ANGELES CA 90071
Business Address 333 SOUTH HOPE STREET 55TH FL LOS ANGELES CA 90071 213-486-9200
Capital Research Global Investors (Filed by) CIK: 0001422848 (see all company filings)

EIN.: 951411037 | State of Incorp.: DE | Fiscal Year End: 0630
Type: SCHEDULE 13G/A